Why the study?
Does immediate deployment of a second device eradicate acute hemolysis following transcatheter closure of patent ductus arteriosus?
Does immediate deployment of a second device eradicate acute hemolysis following transcatheter closure of patent ductus arteriosus?
Immediate deployment of a second device is a viable alternative to surgery for treating acute hemolysis following transcatheter closure of patent ductus arteriosus.
May avoid retrieval or surgery in select post-PDA hemolysis cases; leaves open need for prospective confirmation before wider adoption.
Two patients who underwent transcatheter closure of patent ductus arteriosus, one with a Rashkind umbrella device and the other with a coil, suffered from acute hemolysis following the procedure. Hemolysis ceased after deployment of second device(s) within 48 hr without needing to retrieve the first devices in either patient. We conclude that immediate deployment of a second device(s) is an alternative to surgery when acute hemolysis occurs following transcatheter closure of ductus.
No takes yet. Share an insight, caveat, or question.
Wang et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: